Dopamine and opioid regulation of the memory retrieval recovery in mice

Behavioural Brain Research

Volumn 79, Issue 1-2, 1996, Pages 23-29

  Dubrovina, N I ^a   Ilyutchenok, R Yu ^a  

^a ENERGY SYSTEMS INSTITUTE   (Russian Federation)

Author keywords

Dopamine receptor; Memory deficit; Opioid receptor; Passive avoidance; Retrieval

Indexed keywords

DOPAMINE RECEPTOR; LEUCINE ENKEPHALIN; PRECLAMOL; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030245592     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(95)00258-8     Document Type: Article

References (46)

1. [1] Bennett, M.C. and Hock, F.J., Interaction between catecholaminergic and opioid systems in an active avoidance task, Behav. Neural Biol., 53 (1990) 258-268.
2. [2] Blumstein, L.K., Crawley, J.N., Davis, L.G. and Baldino, Jr. F., Neuropeptide modulation of apomorphine-induced stereotyped behavior, Brain Res., 404 (1987) 293-300.
3. [4] Castellano, C., Cestari, V., Cabib, S. and Puglisi-Allegra, S., Post-training dopamine receptor agonists and antagonists affect memory storage in mice irrespective their selectivity for D1 or D2 receptors, Behav. Neural Biol., 56 (1991) 283-291.
4. [5] Clark, D., Salah, R.S. and Galloway, M.P., Differential agonist profile of the enantiomers of 3PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine, Synapse, 8 (1991) 169-176.
5. [6] Dilts, R.P. and Kalivas, P.W., Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D-penicillamine, 5-D-penicillamine] enkephalin(125 I-DPDPE), Synapse, 6 (1990) 121-132.
6. [7] Dray, A. and Numan, L., Selective delta-opioid receptor antagonism by ICI 174,864 in the central nervous system, Peptides, 5 (1984) 1015-1016.
7. [8] Drukarch, B. and Stoof, J.C., D-2 dopamine autoreceptor selective drugs: do they really exist?, Life Sci., 5 (1990) 361-376.
8. [9] Eghbali, M., Santoro, C., Paredes, W., Gardner, E. and Zukin, R.S., Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions, Proc. Natl. Acad. Sci. USA, 84 (1987) 6582-6586.
9. [10] Engber, T.M., Boldry, R.C., Kuo, S. and Chase, T.N., Dopaminergic modulation of striatal neuropeptides: differential effects of D-1 and D-2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin, Brain Res., 581 (1992) 261-268.
10. [11] Gallagher, M., Rapp, P.R. and Fanelli, R.J., Opiate antagonist facilitation of time-dependent memory processes: dependence upon intact norepinephrine function. Brain Res., 347 (1985) 284-290.
11. [12] Ilyutchenok, R.Yu., Dubrovina, N.I. and Parchomenko, R.I., Effect of quinpirole on memory trace retrieval under amnesia, Pharmacol. Toxicol., 52 (1989) 24-27 (Russian).
12. [13] Izquierdo, I., The role of an endogenous amnesic mechanism mediated by brain beta-endorphin in memory modulation, Braz. J. Med. Biol Res., 15 (1982) 119-134.
13. [14] Izquierdo, I. and Graudenz, M., Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition, Psychopharmacology, 67 (1980) 265-268.
14. [15] Izquierdo, I. and Netto, C.A., Dual action of post-training naloxone on memory, Behav. Neural Biol., 53 (1990) 140-145.
15. [16] Jiang, H.K., McGinty, J.F. and Hong, J.S., Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor sybtypes, Brain Res., 507 (1990) 57-64.
16. [17] Kalivas, P.W. and Duffy, P., Effects of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens, J. Neurosci., 10 (1990) 2940-2949.
17. [18] Kosterlitz, H.W. and Paterson, S.J., Types of opioid receptors: relation to antinociception, Phil. Trans. R. Soc. Lond., 308 (1985) 291-297.
18. [19] Kruglikov, R.I., Orlova, N.V., Getzova, V.M. and Matz, V.N., Dependence of the effect produced by met-enkephalin on the learning and memory from activity of monoaminergic systems, Neurochemia, 2 (1983) 3-10 (in Russian).
19. [20] Leander, J.D., Gesselchen, P.D. and Mendelsohn, L.G., Opioid antinociceptive effects of delta-receptor antagonists. Pharmacol. Biochem. Behav., 29 (1988) 351-355.
20. [21] Manier, M., Abrous, D.N., Feuerstein, C., LeMoal, M. and Herman, J.P., Increase of striatal methionine enkephalin content following lesion of the nigro-striatal dopaminergic pathway in adult rats and reversal following the implantation of embrionic dopaminergic neurons: a quantitative immunohistochemical analysis, Neuroscience, 42 (1991) 427-439.
21. [22] Martin, J.R. and Takemori, A.E., Further evidence that a single dose of an opiate can increase dopamine receptor sensitivity in mice, Eur. J. Pharmacol., 135 (1987) 203-209.
22. [23] Martinez, J.L., Hernandez, R.V. and Rodriguez, S.B., D-Pen2-[D-Pen5]enkephalin impairs acquisition and enhances retention of an one-way active avoidance response in rats, Peptides, 13 (1992) 885-889.
23. [24] McGaugh, J.L., Involvement of hormonal and neuromodulatory systems in the regulation of memory storage, Annu. Rev. Neurosci., 12 (1989) 255-287.
24. [25] McGaugh, J.L., Introini-Collison, I.B. and Nagahara, A.H., Memory-enhancing effects of posttraining naloxone: involvement of beta-noradrenergic influences in the amygdaloid complex, Brain Res., 446 (1988) 37-49.
25. [26] Miller, R., Cortico-striatal and cortico-limbic circuits: a two-tiered model of learning and memory functions. In: H.J. Markowitsch (Ed.), Information Processing by the Brain: Views and Hypotheses from a Cognitive-Physiological Perspective, Hans Huber Press, Bern, 1988, pp. 179-198.
26. [27] Mocehetti, I., Naranjo, J.R. and Costa, E., Regulation of striatal enkephalin turnover in rats receiving antagonists of specific dopamine receptor subtypes, J. Pharmacol. Exp. Ther., 241 (1987) 1120-1124.
27. [28] Morelli, M., Fenu, S. and DiChiara, G., Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors, Brain Res., 487 (1989) 120-130.
28. [29] Morris, B.J., Hollt, V. and Herz, A., Dopaminergic regulation of striatal proenkephalin mRNA and prodynorphin mRNA: Contrasting effects of D1 and D2 antagonists, Neuroscience, 25 (1988) 525-532.
29. [30] Napier, T.C., Dopamine receptors in the ventral pallidum regulate circling induced by opioids injected into the ventral pallidum, Neuropharmacology, 31 (1992) 1127-1136.
30. [31] Normand, E., Popovici, T., Ontaniente, B., Fellmann, D., Piatier-Tonneau, D., Auffray, C. and Bloch, B., Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons, Brain Res., 439 (1988) 39-46.
31. [32] Quartermain, D., The role of catecholamines in memory processing. In: The Physiological Basic of Memory, Academic Press, New York, 1983, pp. 387-423.
32. [33] Ritzmann, R.F., Lee, J.M. and Fields, J.Z., Peptide inhibition of morphine-induced dopaminergic supersensitivity, Life Sci., 31 (1982) 2287-2290.
33. [34] Robustelli, F. and Jarvik, M.E., Retrograde amnesia from detention, Physiol. Behav., 3 (1968) 543-547.
34. [35] Rooney, K.F., Armstrong, R.A. and Sewell, R.D.E., Increased dopamine receptor sensitivity in the rat following acute administration of safentanil, U-50,488H, and D-Ala2-D-Leu5-enkephalin, Naunyn-Schmiedeberg's Arch. Pharmacol., 343 (1991) 458-462.
35. [36] Rothman, R. and Westfall, T.C., Further evidence for an opioid receptor complex, J. Neurobiol., 14 (1983) 341-349.
36. [37] Shippenberg, T.S., Bals-Kubik, R. and Herz, A., Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D1 vs D2 dopamine receptors, J. Pharmacol. Exp. Ther., 265 (1993) 53-59.
37. [38] Schoffelmeer, N.M., Van Vliet, B.J., De Vries, T.J., Heijna, M.H. and Mulder, A.H., Regulation of brain neurotransmitter release and of adenylate cyclase activity by opioid receptors, Biochem. Soc. Trans., 20 (1992) 449-453.
38. [39] Schulteis, G. and Martinez, J.L., ICI 174,864, a selective delta opioid antagonist, reverses the learning impairment produced by [leu] enkephalin. Psychopharmacology, 100 (1990) 102-109.
39. [40] Seeman, P., Brain dopamine receptors, Pharmacol. Res., 32 (1981) 229-313.
40. [41] Spanagel, R., Herz, A. and Shippenberg, T.S., Modulation of the mesolimbic dopaminergic system by beta-endorphin (1-27) as assessed by microdialysis, Eur. J. Pharmacol., 200 (1991) 319-324.
41. [42] Speciale, S.G., Manaye, K.F., Sadea, M. and German, D.C., Opioid receptors in midbrain dopaminergic regions of the rat. II. Kappa and delta receptor autoradiography, J. Neural Transm., 91 (1993) 53-66.
42. [43] Stinus, L., Winnock, M. and Kelley, A.E., Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates, Psychopharmacology, 85 (1985) 323-328.
43. [44] Timmermans, P.B. and Thoolen, M.J., Autoreceptors in the central nervous system, Med. Res. Rev., 3 (1987) 307-332.
44. [45] Tsuruta, K., Frey, E.A., Grewe, C.W., Cote, T.E., Eskay, R.L. and Kebabian, J.W., Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor, Nature, 292 (1981) 463-465.
45. [46] White, N.M., Packard, M.G. and Seamans, J., Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect, Behav. Neural Biol., 53 (1993) 230-241.
46. [47] Wolf, M.E. and Roth, R.H., Dopamine autoreceptors. In I. Creese (Ed.), Dopamine Receptors. New York, 1986, pp. 45-96.